Elimination of proliferating cells from stem cell-derived grafts
AssigneeResearch Development Foundation
InventorsKarl-Heinz KRAUSE, Michel DUBOIS-DAUPHIN, Vannary TIENG CAULET
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for a suicide gene approach comprising an expression vector comprising a cell cycle-dependent promoter driving the expression of a suicide gene. Also provided herein are methods to render proliferative cells sensitive to a prodrug after transplantation but avoids expression of the suicide gene in post-mitotic cells, such as neurons.
Claims44
An expression vector comprising a cell cycle-dependent promoter operatively linked to a suicide gene coding sequence, wherein the suicide gene is cytomegalovirus (CMV) UL97 or mutant herpes simplex virus thymidine kinase (HSV-TK).
Dependencies are inferred from the claim text.